Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HMGN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | TRIP10 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | CXXC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | AVPI1 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | CEP68 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | KIAA1683 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | FKBP10 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |